Загрузка страницы

Cramer's lightning round: I like Eli Lilly over Biogen and Cassava Sciences

"Mad Money" host Jim Cramer answers callers' stock questions at rapid speed during Tuesday's edition of the lightning round. Sign up and learn more about the CNBC Investing Club with Jim Cramer https://www.cnbc.com/investingclub/x

Cassava Sciences: “This is not the one. I don’t think they have it. I don’t think Biogen has it, even though Medicare is going to pay for it. I think Eli Lilly has it, which is why we keep buying that one for the charitable trust.”

Root: “Roots is a really great restaurant in Summit, New Jersey. Root, the one that you’re referring to, is a not-so-great insurance technology company which I think is a [sell].”

Zeta Global: “There are so many of those. We’ve got so many of those. I’m going to tell you to buy Salesforce, OK? Just buy Salesforce, then we don’t have to fool around. We don’t have to worry about the new young ones. We can go with the established ones.”

Doximity: “I know the stock has been all over the place of late -- up and down, up and down. I remain convinced that the doctors love the product and therefore, [buy, buy, buy].”

ViacomCBS: “There’s been insider buying in ViacomCBS and that intrigues me, and I think the stock is not expensive at all.”

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-credit-cards/

#CNBC
#CNBCTV

Видео Cramer's lightning round: I like Eli Lilly over Biogen and Cassava Sciences канала CNBC Television
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
17 ноября 2021 г. 5:43:38
00:03:20
Другие видео канала
U.S. mid-caps are a great diversifier, says John Hancock's Emily RolandU.S. mid-caps are a great diversifier, says John Hancock's Emily RolandRetail investors are joining in on the 'Magnificent 7' hypeRetail investors are joining in on the 'Magnificent 7' hypeOpening Bell, November 4, 2022Opening Bell, November 4, 2022Nike: Here's why Oppenheimer upgraded the stockNike: Here's why Oppenheimer upgraded the stockBreaking down shares of Hilton, Expedia and Match GroupBreaking down shares of Hilton, Expedia and Match GroupNow is a time to own growth and sell some, says T. Rowe's Sebastien PageNow is a time to own growth and sell some, says T. Rowe's Sebastien PageThree-Stock Lunch: Tidewater, Progressive & CRH PLCThree-Stock Lunch: Tidewater, Progressive & CRH PLC'We expect moderation this year' in consumer spending, says NRF CEO Matt Shay'We expect moderation this year' in consumer spending, says NRF CEO Matt ShayExisting home sales in May were essentially flatExisting home sales in May were essentially flatLockheed Martin sees record order volume in 2022 as earnings beat estimatesLockheed Martin sees record order volume in 2022 as earnings beat estimatesTD Cowen's Ritu Bara talks Sarepta stock skyrocketing on FDA gene therapy approvalTD Cowen's Ritu Bara talks Sarepta stock skyrocketing on FDA gene therapy approvalA renter's experience of the housing market really depends on where they are right now: Igor PopovA renter's experience of the housing market really depends on where they are right now: Igor PopovCFRA's Sam Stovall: The projected S&P decline is due to the 10-year yield and inflation readingsCFRA's Sam Stovall: The projected S&P decline is due to the 10-year yield and inflation readingsCDK cyberattack hits U.S. auto dealers for third day in a rowCDK cyberattack hits U.S. auto dealers for third day in a rowCompass CEO: Supply and demand indicators suggest a modest shift towards a homebuyer's marketCompass CEO: Supply and demand indicators suggest a modest shift towards a homebuyer's marketClean Start: This clean-tech startup transforms carbon emissions into vodkaClean Start: This clean-tech startup transforms carbon emissions into vodkaCalls of the Day: Palo Alto, Tesla and Freeport-McMoranCalls of the Day: Palo Alto, Tesla and Freeport-McMoranAI trade is at a 'short-term, tactical top', says Cantor Fitzgerald's Eric JohnstonAI trade is at a 'short-term, tactical top', says Cantor Fitzgerald's Eric JohnstonProlonged high rates will be 'corrosive' to economy, says Moody's Mark ZandiProlonged high rates will be 'corrosive' to economy, says Moody's Mark ZandiVenture capital veteran Alan Patricof: The startup business has never been better than it is nowVenture capital veteran Alan Patricof: The startup business has never been better than it is nowExpect some rotation during earnings season, says Morgan Stanley's Chris ToomeyExpect some rotation during earnings season, says Morgan Stanley's Chris Toomey
Яндекс.Метрика